Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 8,494,151 | 0 | $373.49M | $428.28M | 22.71% | +$54.79M |
| Vaxcyte, Inc.(PCVX) | 1,100,000 | 1,000,000 | -100,000 | $83.06M | $114.27M | 6.06% | +$31.21M |
| Arcellx Inc COMMON STOCK | 1,525,000 | 1,250,000 | -275,000 | $84.16M | $104.39M | 5.54% | +$20.22M |
| Longboard Pharmaceuticals In | 2,790,462 | 2,790,462 | 0 | $75.43M | $93.01M | 4.93% | +$17.58M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,006,534 | 3,406,534 | +400,000 | $54.15M | $90.92M | 4.82% | +$36.77M |
| EyePoint, Inc.(EYPT) | 8,325,000 | 8,325,000 | 0 | $72.43M | $66.52M | 3.53% | -$5.91M |
| Rapport Therapeutics, Inc.(RAPP) | 2,940,283 | 2,940,921 | +638 | $68.39M | $60.23M | 3.19% | -$8.16M |
| Crinetics Pharmaceuticals In | 1,350,000 | 1,100,000 | -250,000 | $60.47M | $56.21M | 2.98% | -$4.26M |
| Praxis Precision Medicines, Inc.(PRAX) | 685,000 | 870,000 | +185,000 | $28.33M | $50.06M | 2.65% | +$21.73M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,025,000 | 2,375,000 | +350,000 | $91.63M | $49.00M | 2.60% | -$42.63M |
| Avidity Biosciences Inc | 425,000 | 1,050,000 | +625,000 | $17.36M | $48.23M | 2.56% | +$30.87M |
| Janux Therapeutics, Inc.(JANX) | 1,050,000 | 1,050,000 | 0 | $43.98M | $47.70M | 2.53% | +$3.72M |
| BridgeBio Pharma, Inc.(BBIO) | 1,858,351 | 1,858,351 | 0 | $47.07M | $47.31M | 2.51% | +$241.6K |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,300,000 | 2,470,000 | +170,000 | $44.18M | $41.00M | 2.17% | -$3.18M |
| Centessa Pharmaceuticals PlcADS | 1,611,600 | 2,561,600 | +950,000 | $14.55M | $40.96M | 2.17% | +$26.41M |
| Merus N V | 840,000 | 740,000 | -100,000 | $49.70M | $36.97M | 1.96% | -$12.73M |
| CG Oncology, Inc.(CGON) | 975,000 | 975,000 | 0 | $30.78M | $36.79M | 1.95% | +$6.01M |
| Insmed Incorporated(INSM) | 675,000 | 500,000 | -175,000 | $45.23M | $36.50M | 1.94% | -$8.72M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $16.07M | $36.07M | 1.91% | +$20.00M |
| Axsome Therapeutics, Inc.(AXSM) | 400,000 | 400,000 | 0 | $32.20M | $35.95M | 1.91% | +$3.75M |
| BioAge Labs, Inc.(BIOA) | 0 | 1,629,529 | +1,629,529 | $0 | $33.89M | 1.80% | +$33.89M |
| Helix Acquisition Corp IiCL A | 2,909,000 | 2,909,000 | 0 | $29.73M | $30.40M | 1.61% | +$668.8K |
| Pharvaris N V COM | 1,466,460 | 1,466,460 | 0 | $27.57M | $27.16M | 1.44% | -$410.6K |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 2,130,000 | 0 | $28.16M | $24.54M | 1.30% | -$3.62M |
| Alumis Inc | 2,147,400 | 2,147,396 | -4 | $28.56M | $22.93M | 1.22% | -$5.63M |
| Cargo Therapeutics Inc | 1,182,563 | 1,182,563 | 0 | $19.42M | $21.82M | 1.16% | +$2.40M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 2,525,000 | 2,325,000 | -200,000 | $23.48M | $21.62M | 1.15% | -$1.86M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 475,000 | 400,000 | -75,000 | $19.50M | $20.96M | 1.11% | +$1.45M |
| Biohaven Ltd.(BHVN) | 801,963 | 401,963 | -400,000 | $27.84M | $20.09M | 1.07% | -$7.75M |
| UroGen Pharma Ltd.(URGN) | 1,650,000 | 1,550,000 | -100,000 | $27.69M | $19.68M | 1.04% | -$8.00M |
| Y-Mabs Therapeutics Inc | 1,450,000 | 1,450,000 | 0 | $17.52M | $19.07M | 1.01% | +$1.55M |
| MBX Biosciences, Inc.(MBX) | 0 | 700,000 | +700,000 | $0 | $18.19M | 0.96% | +$18.19M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 500,000 | 500,000 | 0 | $13.59M | $16.45M | 0.87% | +$2.85M |
| ArriVent BioPharma, Inc.(AVBP) | 515,000 | 585,462 | +70,462 | $9.55M | $13.76M | 0.73% | +$4.21M |
| Anaptysbio Inc | 0 | 342,465 | +342,465 | $0 | $11.47M | 0.61% | +$11.47M |
| Korro Bio, Inc.(KRRO) | 265,826 | 265,826 | 0 | $9.00M | $8.88M | 0.47% | -$119.6K |
| Silence Therapeutics plcADS(SLN) | 625,000 | 400,000 | -225,000 | $11.88M | $7.27M | 0.39% | -$4.60M |
| Engene Holdings Inc COM | 1,000,000 | 1,000,000 | 0 | $9.43M | $6.60M | 0.35% | -$2.83M |
| Stoke Therapeutics, Inc.(STOK) | 427,163 | 427,163 | 0 | $5.77M | $5.25M | 0.28% | -$521.1K |
| Neurogene Inc.(NGNE) | 107,344 | 107,344 | 0 | $3.91M | $4.50M | 0.24% | +$597.9K |
| GH Research PLC(GHRS) | 593,043 | 593,043 | 0 | $6.91M | $3.97M | 0.21% | -$2.95M |
| Yarrow Bioscience Inc(YARW) | 1,394,336 | 1,394,336 | 0 | $2.75M | $2.62M | 0.14% | -$125.5K |
| Verve Therapeutics Inc | 350,000 | 350,000 | 0 | $1.71M | $1.69M | 0.09% | -$14.0K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 103,633 | +103,633 | $0 | $1.60M | 0.08% | +$1.60M |
| Rapt Therapeutics Inc | 496,750 | 496,750 | 0 | $1.52M | $998.5K | 0.05% | -$516.6K |
| Compass Therapeutics, Inc.(CMPX) | 2,030,823 | 0 | -2,030,823 | $2.03M | $0 | — | -$2.03M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,125,000 | 0 | -1,125,000 | $19.62M | $0 | — | -$19.62M |
| IDEAYA Biosciences, Inc.(IDYA) | 245,000 | 0 | -245,000 | $8.60M | $0 | — | -$8.60M |
| Lantheus Holdings, Inc.(LNTH) | 75,000 | 0 | -75,000 | $6.02M | $0 | — | -$6.02M |
| Mersana Therapeutics Inc | 2,600,000 | 0 | -2,600,000 | $5.23M | $0 | — | -$5.23M |
| Sarepta Therapeutics, Inc.(SRPT) | 125,000 | 0 | -125,000 | $19.75M | $0 | — | -$19.75M |